Advertisements



Mallinckrodt says StrataGraft to be evaluated in Phase 3 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

Mallinckrodt says StrataGraft Phase 3 trial met both primary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2019

Mallinckrodt"s stock soars after last-stage trial of StrataGraft tissues meets key targets

Shares of Mallinckrodt PLC soared 19% in premarket trading Monday, after the drugmaker said a phase 3 trial of its investigational StratGraft regenerative tissue met both primary endpoints of efficacy and safety. "R.....»»

Category: topSource: marketwatchSep 23rd, 2019

Mallinckrodt announces publication of results from Phase 1b trial of StrataGraft

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2019

Mallinckrodt"s Phase 3 trial of terlipresin in HRS-1 meets primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2019

Mallinckrodt"s stock shoots up after positive phase 3 trial data on HRS-1 treatment

Shares of Mallinckrodt PLC shot up 11% in premarket trading Thursday, after .....»»

Category: topSource: marketwatchAug 15th, 2019

Mallinckrodt halts Phase 2B trial investigating use of Acthar gel in ALS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2019

Mallinckrodt completes enrollment of Phase 3 terlipressin CONFIRM trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

Mallinckrodt reports retrospective analysis on Phase 3 REVERSE trial data at ILC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Mallinckrodt subsidiary completes patient enrollment for StrataGraft trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019

Mallinckrodt completes enrollment of Phase 4 clinical trial of H.P. Acthar Gel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Celgene shares lift on positive results for cancer drug trial

Celgene Corp. shares rose 1.6% in Tuesday premarket trade after the company reported positive results from a phase 3 cancer trial after-hours the previous day. The trial evaluated Celgene's chemotherapy drug Revlimid .....»»

Category: topSource: marketwatchJul 24th, 2018

Mallinckrodt enrolls first patient in Phase 2 DMD trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

Endocyte Announces FDA"s Acceptance of Trial Endpoint Change

177Lu-PSMA-617, a prostate specific membrane antigen-targeted radioligand therapy, is Endocyte's (ECYT) lead program. It is being evaluated in a phase III study for mCRPC for PSMA-positiv.....»»

Category: personnelSource: nytSep 11th, 2018

Mallinckrodt completed open-label phase of Phase 4 H.P. Acthar Gel trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2019

Rocket says Phase 1 trial establishes feasibility of commercial Process B for FA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall4 hr. 46 min. ago

Innate Pharma reports long-term data from Phase III trial of Lumoxiti

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 46 min. ago

Blueprint announces initial data from Phase 2 Pioneer trial in mastocytosis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 46 min. ago

Epizyme announces "positive, mature data" for Phase 2 trial of tazemetostat

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 7th, 2019

Corvus reports initial results from Phase 1/1b trial of CPI-818

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 7th, 2019

SNGX: CTCL Phase 3 Trial Fully Enrolled; Data in 1Q20…

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT read more.....»»

Category: blogSource: benzingaDec 5th, 2019